• By Dana Sparks

Mayo Clinic Genomic Analysis Lends Insight to Prostate Cancer

May 23, 2013

Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. Mayo Clinic pathologist and one of the authors on the paper, John Cheville, M.D., says, “This is the first study to examine DNA alterations using next generation sequencing in adjacent Gleason patterns in the same tumor allowing us to correlate genomics with changes in pathology."  

The findings appear online in the journal Cancer Research.

Click here for news release